The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Diagnostics Market Research Report 2025
Synopsis
Diagnostic tests analyze biological samples (blood, saliva, urine, skin, etc.) taken from patients. Theydetect and quantify the presence of bacteria, viruses, fungi or parasites as well as substances secreted by the human body – for example by measuring the level of a hormone or a marker specific to a disease.
The global Clinical Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Clinical Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Diagnostics.
Report Scope
The Clinical Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Diagnostics market comprehensively. Regional market sizes, concerning products by Product, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Product, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Sonic Healthcare
Charles River Laboratories
Quest Diagnostics
Bioscientia Healthcare
Bio-Reference Laboratories
ARUP Laboratories
Abbott Laboratories
Labco
Healthscope
Laboratory Corporation Of America Holdings
Qiagen
Genoptix Medical Laboratory
Genzyme
Clarient
Segment by Product
Instruments
Reagents
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Product, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diagnostic tests analyze biological samples (blood, saliva, urine, skin, etc.) taken from patients. Theydetect and quantify the presence of bacteria, viruses, fungi or parasites as well as substances secreted by the human body – for example by measuring the level of a hormone or a marker specific to a disease.
The global Clinical Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Clinical Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Diagnostics.
Report Scope
The Clinical Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Diagnostics market comprehensively. Regional market sizes, concerning products by Product, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Product, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Sonic Healthcare
Charles River Laboratories
Quest Diagnostics
Bioscientia Healthcare
Bio-Reference Laboratories
ARUP Laboratories
Abbott Laboratories
Labco
Healthscope
Laboratory Corporation Of America Holdings
Qiagen
Genoptix Medical Laboratory
Genzyme
Clarient
Segment by Product
Instruments
Reagents
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Product, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Product
1.2.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Diagnostics Market Perspective (2019-2030)
2.2 Clinical Diagnostics Growth Trends by Region
2.2.1 Global Clinical Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Clinical Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Clinical Diagnostics Market Dynamics
2.3.1 Clinical Diagnostics Industry Trends
2.3.2 Clinical Diagnostics Market Drivers
2.3.3 Clinical Diagnostics Market Challenges
2.3.4 Clinical Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Diagnostics Players by Revenue
3.1.1 Global Top Clinical Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Clinical Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Diagnostics Revenue
3.4 Global Clinical Diagnostics Market Concentration Ratio
3.4.1 Global Clinical Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Diagnostics Revenue in 2023
3.5 Clinical Diagnostics Key Players Head office and Area Served
3.6 Key Players Clinical Diagnostics Product Solution and Service
3.7 Date of Enter into Clinical Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Diagnostics Breakdown Data by Product
4.1 Global Clinical Diagnostics Historic Market Size by Product (2019-2024)
4.2 Global Clinical Diagnostics Forecasted Market Size by Product (2025-2030)
5 Clinical Diagnostics Breakdown Data by Application
5.1 Global Clinical Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Clinical Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Diagnostics Market Size (2019-2030)
6.2 North America Clinical Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Diagnostics Market Size by Country (2019-2024)
6.4 North America Clinical Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Diagnostics Market Size (2019-2030)
7.2 Europe Clinical Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Diagnostics Market Size by Country (2019-2024)
7.4 Europe Clinical Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Clinical Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Diagnostics Market Size (2019-2030)
9.2 Latin America Clinical Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Clinical Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Clinical Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthcare
11.1.1 Siemens Healthcare Company Detail
11.1.2 Siemens Healthcare Business Overview
11.1.3 Siemens Healthcare Clinical Diagnostics Introduction
11.1.4 Siemens Healthcare Revenue in Clinical Diagnostics Business (2019-2024)
11.1.5 Siemens Healthcare Recent Development
11.2 Sonic Healthcare
11.2.1 Sonic Healthcare Company Detail
11.2.2 Sonic Healthcare Business Overview
11.2.3 Sonic Healthcare Clinical Diagnostics Introduction
11.2.4 Sonic Healthcare Revenue in Clinical Diagnostics Business (2019-2024)
11.2.5 Sonic Healthcare Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Clinical Diagnostics Introduction
11.3.4 Charles River Laboratories Revenue in Clinical Diagnostics Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Clinical Diagnostics Introduction
11.4.4 Quest Diagnostics Revenue in Clinical Diagnostics Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 Bioscientia Healthcare
11.5.1 Bioscientia Healthcare Company Detail
11.5.2 Bioscientia Healthcare Business Overview
11.5.3 Bioscientia Healthcare Clinical Diagnostics Introduction
11.5.4 Bioscientia Healthcare Revenue in Clinical Diagnostics Business (2019-2024)
11.5.5 Bioscientia Healthcare Recent Development
11.6 Bio-Reference Laboratories
11.6.1 Bio-Reference Laboratories Company Detail
11.6.2 Bio-Reference Laboratories Business Overview
11.6.3 Bio-Reference Laboratories Clinical Diagnostics Introduction
11.6.4 Bio-Reference Laboratories Revenue in Clinical Diagnostics Business (2019-2024)
11.6.5 Bio-Reference Laboratories Recent Development
11.7 ARUP Laboratories
11.7.1 ARUP Laboratories Company Detail
11.7.2 ARUP Laboratories Business Overview
11.7.3 ARUP Laboratories Clinical Diagnostics Introduction
11.7.4 ARUP Laboratories Revenue in Clinical Diagnostics Business (2019-2024)
11.7.5 ARUP Laboratories Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Clinical Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in Clinical Diagnostics Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Labco
11.9.1 Labco Company Detail
11.9.2 Labco Business Overview
11.9.3 Labco Clinical Diagnostics Introduction
11.9.4 Labco Revenue in Clinical Diagnostics Business (2019-2024)
11.9.5 Labco Recent Development
11.10 Healthscope
11.10.1 Healthscope Company Detail
11.10.2 Healthscope Business Overview
11.10.3 Healthscope Clinical Diagnostics Introduction
11.10.4 Healthscope Revenue in Clinical Diagnostics Business (2019-2024)
11.10.5 Healthscope Recent Development
11.11 Laboratory Corporation Of America Holdings
11.11.1 Laboratory Corporation Of America Holdings Company Detail
11.11.2 Laboratory Corporation Of America Holdings Business Overview
11.11.3 Laboratory Corporation Of America Holdings Clinical Diagnostics Introduction
11.11.4 Laboratory Corporation Of America Holdings Revenue in Clinical Diagnostics Business (2019-2024)
11.11.5 Laboratory Corporation Of America Holdings Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Clinical Diagnostics Introduction
11.12.4 Qiagen Revenue in Clinical Diagnostics Business (2019-2024)
11.12.5 Qiagen Recent Development
11.13 Genoptix Medical Laboratory
11.13.1 Genoptix Medical Laboratory Company Detail
11.13.2 Genoptix Medical Laboratory Business Overview
11.13.3 Genoptix Medical Laboratory Clinical Diagnostics Introduction
11.13.4 Genoptix Medical Laboratory Revenue in Clinical Diagnostics Business (2019-2024)
11.13.5 Genoptix Medical Laboratory Recent Development
11.14 Genzyme
11.14.1 Genzyme Company Detail
11.14.2 Genzyme Business Overview
11.14.3 Genzyme Clinical Diagnostics Introduction
11.14.4 Genzyme Revenue in Clinical Diagnostics Business (2019-2024)
11.14.5 Genzyme Recent Development
11.15 Clarient
11.15.1 Clarient Company Detail
11.15.2 Clarient Business Overview
11.15.3 Clarient Clinical Diagnostics Introduction
11.15.4 Clarient Revenue in Clinical Diagnostics Business (2019-2024)
11.15.5 Clarient Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
